Skip to main content
. 2021 Sep 14;13(9):e17982. doi: 10.7759/cureus.17982

Table 12. The effect of comorbidities on quality of life.

Data are presented as median (interquartile range) or mean±standard deviation.

F: one way ANOVA (Sidak post-hoc test), H: Kruskal-Wallis H test (Dunn-Bonferroni post-hoc test)

VAS: visual analogue scale

Quality of life Hypertension Diabetes Other comorbidities No comorbidity H or F (3) p
SF-36 Physical functioning 75 (60) 55 (75) 80 (60) 70 (67.50) 0.29 0.96
SF-36 Limitations due to physical health 75 (75) 75 (100) 100 (100) 75 (87.50) 0.58 0.90
SF-36 Limitations emotional problems 100 (100) 66.67 (100) 100 (33.33) 66.67 (100) 1.47 0.69
SF-36 Energy fatigue 50 (35) 40 (50) 30 (35) 60 (37.50) 4.86 0.18
SF-36 Emotional wellbeing 52 (28) 64 (36) 40 (24) 48 (28) 4.97 0.17
SF-36 Social functioning 62.50 (75) 75 (50) 75 (75) 75 (50) 1.12 0.77
SF-36 pain 77.50 (61.25) 100 (40) 100 (55) 100 (38.75) 1.82 0.61
SF-36 General health 40 (27.50) 45 (35) 25 (50) 50 (22.50) 3.11 0.37
MacNew emotional 4.57 (1.38) 4.71 (2.43) 4.57 (1.15) 4.57 (1.21) 1.29 0.73
MacNew physical 4.85 (2.43) 4.23 (4.07) 5 (2.53) 4.92 (2.12) 0.89 0.83
MacNew social 4.31 (2.07) 3.69 (3.39) 4.92 (1.77) 4.77 (1.92) 1.56 0.67
MacNew global 4.41 (1.61) 4.30 (3.26) 4.44 (1.67) 4.74 (1.15) 0.54 0.91
EQ-5D-5L index 0.56±0.3 0.51±0.37 0.56±0.3 0.53±0.33 F= 0.11 0.95
Health assessment VAS 62.07±17.45 69.64±21.81 65.91±29.48 72.59±14.8 F=1.52 0.22